Results 131 to 140 of about 304,742 (351)
What's new? While early diagnosis of triple‐negative breast cancer (TNBC) is associated with heightened responsiveness to chemotherapy, biomarkers that can be detected noninvasively are needed to support early TNBC diagnosis. Our study suggests that such markers may exist in the form of methylation signatures in cell‐free DNA. Evaluation of methylation
Mehdi Manoochehri+13 more
wiley +1 more source
Several investigators have identified Epstein-Barr virus (EBV) particles in breast carcinomas, a fact that supports a role for EBV in mammary tumorigenesis. The possible mechanism involved in this process is not clear.
A. Ribeiro-Silva+3 more
doaj +3 more sources
Potential biomarkers of ductal carcinoma in situ progression
Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
Raquel Spinassé Dettogni+17 more
doaj +1 more source
HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury
Hepatocyte Nuclear Factor 3 alpha (HNF3α) is significantly upregulated in renal tubular epithelial cells of CKD patients and fibrotic mice. Deletion of HNF3α mitigates IRI‐induced renal fibrosis, while overexpression worsens it. HNF3α directly regulates NCK‐associated protein 1‐like (Nckap1l), whose overexpression exacerbates fibrosis.
Ling Hou+7 more
wiley +1 more source
Background According to previous studies, tall cell carcinoma with reversed polarity can be easily distinguished from ductal carcinoma in situ based on the absence of myoepithelium and a typical histologic feature.
Ruiqi Zhong+3 more
doaj +1 more source
Macrophages promote the progression of premalignant mammary lesions to invasive cancer. [PDF]
Breast cancer initiation, progression and metastasis rely on a complex interplay between tumor cells and their surrounding microenvironment. Infiltrating immune cells, including macrophages, promote mammary tumor progression and metastasis; however, less
Anderson+49 more
core +1 more source
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
HuR is a ubiquitously expressed mRNA-binding protein. Intracellular localization of HuR is predominantly nuclear, but it shuttles between the nucleus and the cytoplasm. In the cytoplasm it can stabilize certain transcripts.
Mira Heinonen+9 more
semanticscholar +1 more source
Spatially resolved multiomics reveals that high‐copper zones are closely associated with tumor metastasis, immune‐desert phenotypes, and oxidative‐phosphorylation (OXPHOS)‐dependent proliferation. A targeted bacterial nanovesicle delivering copper‐depleting agents effectively reduces tumor copper levels, inhibits OXPHOS‐dependent tumor growth, and ...
Lin Chen+16 more
wiley +1 more source
Secretory Breast Carcinoma: A Case Report with MRI Findings
Secretory carcinoma of the breast is an extremely rare, clinically and histologically distinct variant of invasive ductal carcinoma, with an indolent growth pattern and a more favorable prognosis than that of typical ductal carcinoma.
Sung Hee Shin+6 more
doaj +1 more source
The contribution of DNA damage repair mechanisms to the progression of normal breast to ductal carcinoma in situ (DCIS) and invasive ductal carcinoma is largely unknown. The purpose of this report was to assess the mRNA expression levels of two important
Jolanta Hybiak+2 more
doaj +1 more source